Intervacc is trading 7.85% up at β¬0.07; the reason for the move remains unclear.
- Searches found no September 30 company announcement or reliable report identifying a specific catalyst.
- The latest company-specific news found was a September 15 announcement that Intervaccβs CEO would present at the Swiss Nordic Bio Conference on October 1. Available reporting does not establish that this prior announcement drove the increase.